rediff.com
rediff.com
Money Find/Feedback/Site Index
      HOME | MONEY | STOCKS | RAPID INFORMATION ON STOCKS & CORPORATES
August 1, 2000

Books
Columnists
Indian Tax
Insurance
Interview
Mutual Funds
NRI Tax
Personal Finance
Personal Banking
Real Estate
Stocks




 Nocil Q1 net profit at Rs 42 million
 National Organic Chemical Industries Ltd has posted a net profit of Rs 42/- million as compared to Rs 46.80 million in the same period last year. Net sales for the quarter ended June 30, 2000 are at Rs 2465/- million as compared to Rs 231.80 million in the same period last year.
Other income has risen from Rs 911/- million in the quarter ended June 30, 99 to Rs 133.30 million in the quarter ended June 30, 2000. In spite of higher cost of raw materials, Company has been able to maintain the profits on account of cost cutting/controls in all its operations.

 Dr. Reddy's Cheminor Drugs merger gets approval, swap ratio 9:25 approved
 The shareholders of Dr. Reddy's Laboratories Ltd. and Cheminor Drugs Ltd. met in Hyderabad on July 31, 2000 in separate High court directed meetings and approved the merger of the two companies, with a swap ratio 9:25. Shareholders of Cheminor Drugs will receive 9 shares of DRL for every 25 shares held by them. Pricewaterhouse Coopers had conducted an independent business valuation exercise earlier this year.

 Hindalco Q1 net profit up by 27.48%
 Hindalco Industries Ltd. has posted a net profit of Rs 1758 million for the quarter ended June 30, 2000 as compared to Rs 1379 million for the same period last year. Net sales for the quarter ended June 30, 2000 are higher by 18.14% at Rs 5652 million as compared to Rs 4784/- million in the quarter ended June 30, 99 Other income for the quarter ended June 30, 2000 is at Rs 307/- million as compared to Rs 297/- million in the quarter ended June 30, 99. The Company has acquired 54.62% Equity Shares in Indian Aluminium Company Limited (Indal) from Alcan Aluminium Limited, Canada. Further, in terms of Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulation 1997, the Company has acquired additional 20% Equity Shares in Indal under Open Offer. The Company has acquired the aggregate stake on 74.62% in Indal for a total consideration of Rs 10053 million. Consequent to this acquisition Indal has become a subsidiary of the Company.

 Wyeth Lederle Q1 net profit up by 44.19%
 Wyeth Lederle Ltd. has reported a net profit of Rs 95.60 million in Q1 2000, as compared to Rs 66.30 million in Q1 1999, an increase of 44.19%. Net sales for Q1 2000 increased by 9.81% to Rs 755.5 million as compared to Rs 688 million in the corresponding quarter of the previous year. Other income for Q1 2000 stood at Rs 12 million as compared to Rs 7 million in the Q1 1999, an increase of 71.43%.

 Aurobindo Pharma Q1 2000 net up by 14.58%
 Aurobindo Pharma Ltd. has reported a net profit of Rs 213 million in Q1 2000 as compared to Rs 185.90 million in Q1 1999, an increase of 14.58%. Net sales for Q1 2000 increased by 16.36% to Rs 2130.30 million as compared to Rs 1830.80 million in the corresponding quarter of the previous year. Other income for Q1 2000 stood at Rs 8.90 million as compared to Rs 9.30 million in the Q1 1999, a decrease of 4.30%. In Q1 2000 the company allotted bonus shares in the ratio 1:1.

 J. B. Chemicals Q1 net up by 4.9%
 J. B. Chemicals and Pharmaceuticals Ltd. reported a Q1 2000 net of Rs 57.71 million as compared to Rs 55.01million in Q1 1999, an increase of 4.90%. Net sales for the quarter ended June 30, 2000, stood at Rs 446.23 million, an increase of 5.9% as compared to Rs 421.37 million reported in Q1 1999. Other income in Q1 2000 was 10.13% lower at Rs 12.75million as compared to Rs 14.18 million in the corresponding quarter of the previous year.
The Scheme for Amalgamating the Pharma Divisions of Ifunik Pharmaceuticals Ltd. & Unique Pharmaceutical Laboratories Ltd. into J.B. Chemicals is being processed for the requisite approvals (including the approval by a specially convened meeting of the Shareholders pursuant to the Orders of the Bombay High Court). As per the Valuation Report Of M/s. Bansi S. Mehta & Co, Chartered Accountants, the Shareholders of the foregoing two companies would be entitled to be allotted Equity Shares in J.B. Chemicals in the ratio of 7 (Seven) such Shares for every 4 (Four) Shares held on the Record Date in Ifunik Pharmaceuticals Ltd and one such share for every one share held on the record date in Unique Pharmaceutical Laboratories Ltd. upon the foregoing Scheme becoming effective after all requisite approvals are obtained.

 Whirlpool India Q1 net up by 151.88%
 Whirlpool of India Ltd has reported a net profit of Rs 167.50 million for the quarter ended June 30, 2000, as compared to Rs 66.50 million in the corresponding quarter of the previous year, an increase of 151.88%. Net sales of the company for Q1 2000 stood at Rs 3385.90 million as compared to Rs 2728.10 million for Q1 1999, an increase of 24.11%. Other income for Q1 2000 increased to Rs 17.60 million as compared to Rs 4.10 million in the corresponding period of the previous year. The company attributed the increase in net profit to revenue growth and margin improvement driven by continuing cost control measures. Dematerialised trading in the shares of the company has become mandatory w.e.f June 26, 2000.

 Ciba Specialty Q1 Net up by 36.67%
 Ciba Specialty Chemicals (India) Ltd. has posted a net profit of Rs 41 million for the quarter ended June 30, 2000 as compared to Rs 30 million in the corresponding quarter of the previous year. Net sales for Q1 2000 stood at Rs 1284 million as compared to Rs 1016 million in Q1 1999. Other income in Q1 2000 stood at Rs 8 million as compared to Rs 9 million in the corresponding quarter of the previous year.
The Company has acquired 1.53 million Equity shares amounting to 51% of the paid up share capital in Diamond Dye-Chem Ltd (DDL) on May 01, 2000, and consequently DDL has become a subsidiary with effect from May 01, 2000.
Ciba Specialty Chemicals Holding Inc., Switzerland, the Company's Parent Company, has concluded sale of the Performance Polymers Division/Business of its wholly owned subsidiary, Ciba Specialty Chemicals Inc, on a worldwide basis effective June 01, 2000 to a Company established by Morgan Grenfell Private Equity Ltd. The consent of the members of the Company will be sought at the AGM to be held on August 01, 2000, for the proposed divestment of Performance Polymers Division/Business of the Company with effect from June 01, 2000.
Pending the consent of the members at the forthcoming AGM, the above result includes net sales of Rs 92 million of the Performance Polymers Division of the Company for the month of June, 2000.

 E.I.D Parry Q1 net down by 29.22%
 E.I.D Parry India limited has reported a net profit of Rs 72.20 million in the quarter ended June 30, 2000 as compared to Rs 102 million in the corresponding period of the previous year. Net sales for the quarter ended June 30, 2000 stood at Rs 2258.90 million as compared to Rs 2235.40 million in Q1 '99. Other income for the quarter ended June 30, 2000 stood at Rs 45.8 million as compared to Rs 1.1 million in the corresponding period of the previous year. Gross profit for the first quarter of last year included Rs 100.3 million being the impact on stock valuation as per revised Mandatory Accounting Standard (AS2) for the inventories held as of June 30, 1999. Trading in shares of the Company has been made compulsory in dematerialised form for all investors with effect from June 26, 2000.

 Swaraj Engines Q1 net down by 29.17%
 Swaraj Engines Ltd has posted a net profit of Rs 25.50 million for the quarter ended June 30, 2000 as compared to Rs 36/- million in the quarter ended June 30, 99. Total Revenue for the quarter ended June 30, 2000 is at Rs 281.10 million as compared to Rs 384.30 million in the same period last year.

 Godrej Soaps Q1 net profit up by 176.39%
 Godrej Soaps Ltd has posted a net profit of Rs 144/- million for the quarter ended June 30, 2000 as compared to Rs 52.10 million in the same period last year. Net sales for the quarter ended June 30, 2000 are higher by 6.25% at Rs 1994.10 million as compared to Rs 1876.80 million in the same period last year.
Other income for the quarter ended June 30, 2000 is at Rs 7/- million as compared to Rs 4.10/- million in the same period last year.
The Board of Directors of Godrej Soaps Limited has decided to make an offer for sale of a part of the company shareholding in Godrej Sara Lee Limited (GSLL) to the public.This would result in becoming GSLL a listed company. The offer for sale would be made by Godrej Soaps limited along with other shareholders. The pricing, timing, exact number of shares and other terms and conditions of the offer would have to be decided in due course of time. After the public issue the management control of GSLL would be with Sara Lee.
The Board of Directors has taken an in principle decision subjects to various approvals including those from shareholders lenders,courts and regulatory authorities to restructure the company by demerging the consumer Products business as a going concern to a new company.This is intended to be a classical merger i.e both the companies having an identical shareholding pattern .The Board has appointed a Committee of Directors which will consider the details of the scheme of demerger and is expected to submit its recommendations within the next six months for a final decision by the Board.

 BSE imposes special margin on Top Cassettes
 BSE has imposed Special Margin in the under mentioned scrip with effect from Tuesday, August 1, 2000.
Sr No Scrip Code Scrip Name Scrip Group Special Margin Per Share (%)
1. 31554 TOP CASSETTES LTD B2 25%

 BSE imposes special margin on Top Cassettes
 BSE has imposed Special Margin in the under mentioned scrip with effect from Tuesday, August 1, 2000.
Sr No Scrip Code Scrip Name Scrip Group Special Margin Per Share (%)
1. 31554 TOP CASSETTES LTD B2 25%

 Tanu Healthcare promoters to dilute stake to TCP Focus Inc, USA
 Tanu Healthcare Ltd. has informed the BSE that the Board of Directors of the company at its meeting held on 26.07.2000, have decided that promoters equity stake be diluted by 7,00,000 equity shares @ Rs.28/- per share to TCP Focus Inc., USA, subject to RBI and necessary approval.

 STG launches digitaltradeb2b.com
 Software Technology Group International Ltd. has informed BSE that the company is in the midst of putting into effect an ambitious expansion programme of its software development division, focusing on high growth areas of activities like B2B e-commerce solutions to the global marketplace. The launch of a B2B e-commerce portal named as digitaltradeb2b.com is the first major step to fulfil the company's e-commerce strategy, which comprises of ERP, Web Enabled Applications, B2B solutions, portals and finally integration with WAP based applications.

 Mindteck considers merger of Nicco Infotech
 The Board of Directors of Mindteck (India) Ltd. at its meeting held on 26.07.2000 has considered the proposal to merge Nicco Infotech Ltd., with the company.

 Kanoria Industries declared Sick by BIFR
 Kanoria Industries Ltd has informed BSE that BIFR has declared the company as a sick industrial company under section 3(1)(o) of the Sick Industrial Companies (Special Provision) Act, 1985 and appointed IDBI as the Operating Agency to examine the viability of the company and formulate a rehabilitation scheme for its revival.

 Dabur Q1 net profit at Rs 71.50 million, approves stock split in 10:1
 Dabur India Ltd. has reported a net profit of Rs 71.50 million for the quarter ended June 30, 2000 as compared to Rs 264.40 million in the same period last year. Net sales for the quarter ended June 30, 2000 are at Rs 2479/- million as against Rs 2335.30 million for the quarter ended 30, 99. Other income has decreased from Rs 15.20 million in JQ 99 to Rs 13.90 million.
The Company recorded 6.2% sales growth for the quarter ended 30th June, 2000. However, the growth in sales is 10% on like to like basis after excluding Foods which has been carved into a 100% subsidiary. Net profit for the quarter was higher by an impressive 35% Vs corresponding quarter during previous year due to cost effective purchasing & better management of fixed costs. Net profit for the quarter ended 30th June, 1999 included non recurring income of Rs 211.70 million from sale of 49% stake in General De Confeteria India Limited.The Company maintained its advertising & promotional expenditure at 11.5% of sales.
The Board approved the sub division (stock split) of each equity share of Rs 10 into 10 equity shares of Rs 1 each.

RISC

Tell us what you think of this feature

HOME | NEWS |BUSINESS | MONEY | SPORTS | MOVIES | CHAT | INFOTECH | TRAVEL
SINGLES | NEWSLINKS | BOOK SHOP | MUSIC SHOP | GIFT SHOP | HOTEL BOOKINGS
AIR/RAIL | WEATHER | MILLENNIUM | BROADBAND | E-CARDS | EDUCATION
HOMEPAGES | FREE EMAIL | CONTESTS | FEEDBACK

Disclaimer